Germany’s Hermes Arzneimittel GmbH is poised to expand its domestic OTC business by acquiring a portfolio of 11 brands from Krewel Meuselbach GmbH for an undisclosed sum.
Scheduled to close on 1 October, the deal will see Hermes add Krewel Meuselbach’s German brands to its OTC business...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?